RN endorses loose stools, belly pain, and hip pain - reported positive urine cultures from [**2159-4-10**] and [**2159-4-14**] with E.Coli, for which they started him on Augmentin on [**2159-4-10**].
?C) (Rectal), Pulse: 93, RR: 14, BP: 110/83, O2Sat: 96%, O2Flow: (Room Air), Pain: 10.
EKG was done, which showed SR @ 84, baseline artifact, no peaked t-waves.
CXR was done, which showed RLL opacity, concerning for atelectasis, pneumonia cannot be excluded in the appropriate clinical setting.
CT head showed no acute intracranial process and volume loss out of proportion to patient's age and non-specific white matter hypodensities may relate to underlying HIV.
UA and urine culture was taken from his uterostomy.
Vitals upon transfer were BP 122/95, RR 16, HR 84, Sat 95%.
Discharge exam: VSS GEN:  Patient lying comfortably in bed nad a+ox1 HEENT:  MMM oropharynx clear NECK:  supple no thyromegaly CV:  rrr no m/r/g RESP: ctab no w/r/r ABD:  soft nt nd bs+ EXTR: no le edema good pedal pulses bilaterally left sided picc line in place DERM:  no rashes, ulcers or petechiae neuro:  cn 2-12 grossly intact non-focal   Pertinent Results: Admission labs: [**2159-4-24**] 02:20PM BLOOD WBC-12.2* RBC-4.40* Hgb-14.7 Hct-48.3 MCV-110* MCH-33.5* MCHC-30.5* RDW-16.1* Plt Ct-392 [**2159-4-24**] 02:20PM BLOOD Neuts-75.5* Lymphs-21.1 Monos-2.5 Eos-0.4 Baso-0.5 [**2159-4-24**] 02:20PM BLOOD  WBC-12.2* Lymph-21 Abs [**Last Name (un) **]-2562 CD3%-60 Abs CD3-1545 CD4%-26 Abs CD4-662 CD8%-33 Abs CD8-850* CD4/CD8-0.8* [**2159-4-24**] 02:20PM BLOOD Glucose-119* UreaN-45* Creat-1.6* Na-131* K-GREATER TH Cl-102 HCO3-19* [**2159-4-24**] 02:20PM BLOOD ALT-25 AST-130* AlkPhos-58 TotBili-0.5 [**2159-4-24**] 02:20PM BLOOD Albumin-4.0 [**2159-4-24**] 02:25PM BLOOD Lactate-2.5* K-5.4* [**2159-4-25**] 05:10AM BLOOD Lactate-1.7  Discharge labs:  Imaging: -CXR ([**2159-4-24**]): Right lower lung opacity, most likely atelectasis, however, pneumonia cannot be excluded in the appropriate clinical setting.
-CT head ([**2159-4-24**]): 1.
If high clinical suspicion for other an alterantive diagnosis, a MRI could be performed.
Discharge labs  [**2159-4-26**] 05:30AM BLOOD WBC-8.4 RBC-2.92* Hgb-9.8* Hct-31.0* MCV-106* MCH-33.6* MCHC-31.6 RDW-16.0* Plt Ct-270 [**2159-4-26**] 01:42PM BLOOD Hct-33.1* [**2159-4-26**] 11:45AM BLOOD Glucose-81 UreaN-24* Creat-0.8 Na-137 K-4.5 Cl-112* HCO3-16* AnGap-14 [**2159-4-25**] 03:44AM BLOOD ALT-13 AST-15 AlkPhos-47 TotBili-0.3  Brief Hospital Course: # ESBL UTI: Patient was being treated with Augmentin at rehab which is inappropiate coverage for ESBL E. coli.
# Possible PNA: Possible PNA seen on admission CXR in LLL; but no cough or pulmonary complaints.
# C. diff colitis: Positive for C. diff on [**4-9**] at [**Hospital1 **].
He was pre-renal at arrival with Cr of 1.6.
His creatinine returned to baseline at 0.8 on day of discharge.
[**Month (only) 116**] be [**1-11**] antiretroviral medications.
He was continued on his home antiretrovirals: Epzicom (abacavir-lamivudine 600-300mg) and kaletra 2 tabs.
# Code status this admission: FULL  # Transitional issues -Continue meropenem for a total of 10 days -continue vancomycin po for 14 days after completing meropenem course -Check cbc, chem 10 panel on [**2159-4-30**] -follow up on b12/folate levels  Medications on Admission: PO vancomycin 125mg PO q6hr Augmentin Bupropion XL 300mg daily Calcium carbonate 1000mg PO qday Divalproex capsule Sprinkle 375mg TID at 9a, 1p, 5p Epzicom 600-300mg qHS Gabapentin 400mg q12hr Kaletra 200-50, two tablet PO qHS Clonazepam 0.5mg PO q12hr, and 0.5mg PO daily prn Anxiety Lactobacillus 1 tab PO qAC Meclizine 12.5mg q12hr Megace ES 625mg/5mL, 5mL PO daily Melatonin 3mg PO qHS MVI Oxycodone 5mg TID at 9a, 1p, 9p; also 5mg PO q4hr prn breakthrough Trazodone 100mg PO qHS Vitamin D3 1000U daily Ranitidine 150mg PO daily Bisacodyl 10mg PR prn Milk of magnesia prn constipation Mylanta prn dsypepsia APAP 650mg PO q6hr prn pain  Discharge Medications: 1. vancomycin 250 mg/5 mL Syringe Sig: One [**Age over 90 **]y Five (125) mg PO Q6H (every 6 hours) for 22 days: End date [**2159-5-17**].
Please have a follow up cbc and chem 10 panel on [**4-30**] at your [**Hospital1 1501**] New medication 1.
